CYTK - Company ID 0001061983
The table below shows CYTOKINETICS INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $88.04M | $18.47M | $7.53M | $94.59M | $70.43M | $55.83M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $416.03M | $339.41M | $330.12M | $240.81M | $159.94M | $96.95M |
| SG&A |
CYTOKINETICS INC reported annual revenue of $88.04M for fiscal year 2025. That is up 376.6% from $18.47M in fiscal 2024. Over the 10 fiscal years shown, annual revenue declined from $106.41M (FY 2016) to $88.04M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $284.27M |
| $215.31M |
| $173.61M |
| $177.98M |
| $96.80M |
| $52.82M |
| Operating income | -$612.26M | -$536.25M | -$496.20M | -$324.20M | -$186.31M | -$93.94M |
| Income tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | -$784.96M | -$589.53M | -$526.24M | -$388.95M | -$215.31M | -$127.29M |
| EPS (diluted) | -$6.54 | -$5.26 | -$5.45 | -$4.33 | -$2.80 | -$1.97 |